𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Photodynamic therapy as a tool for suppressing the haematogenous dissemination of tumour cells

✍ Scribed by F. Fischer; W. Maier-Borst; W.-J. Lorenz

Publisher
Elsevier Science
Year
1998
Tongue
English
Weight
796 KB
Volume
43
Category
Article
ISSN
1011-1344

No coin nor oath required. For personal study only.

✦ Synopsis

The chance of most cancer patients surviving their disease is to a high degree dependent on the status of the metastatic processes. One general route of cancer-cell dissemination is passive transport in the blood stream, i.e., haematogenous dissemination. In this study we try to find an answer to the following question: is it possible to use photodynamic therapy for suppressing the haematogenous dissemination of cancer cells? In first in vitro experiments we incubated CX1 cells (colon carcinoma cells) with two photosensitizers, Photofrin II and mesotetra(hydroxyphenyl)chlorin (mTHPC). We added the cells to fresh whole blood and irradiated the blood with suitable laser light in a flow-through irradiation system. The tumour-cell survival fraction (SF) was determined with plating efficiency. Using Photofrin II we observed a minimal tumour-cell survival in blood of SF = 3.5% and using mTHPC we measured SF = 0.02%. These results encourage further investigations concerning the use of photodynamic therapy for suppressing haematogenous dissemination.

πŸ“œ SIMILAR VOLUMES

Polyelectrolyte microcapsules with entra
Polyelectrolyte microcapsules with entrapped multicellular tumor spheroids as a novel tool to study the effects of photodynamic therapy
✍ Daria S. Zaytseva-Zotova; Olga O. Udartseva; Elena R. Andreeva; Artur Bartkowiak πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 504 KB

## Abstract In the current study, semi‐permeable alginate‐oligochitosan microcapsules for multicellular tumor spheroids (MTS) generation were elaborated and tested, to estimate a response of the microencapsulated MTS (MMTS) to photodynamic therapy (PDT). The microcapsules (mean diameter 600 ΞΌm) wit

Assessing the efficacy of targeted thera
Assessing the efficacy of targeted therapy using circulating epithelial tumor cells (CETC): the example of SERM therapy monitoring as a unique tool to individualize therapy
✍ Katharina Pachmann; Oumar Camara; Annika Kohlhase; Carola Rabenstein; Torsten Kr πŸ“‚ Article πŸ“… 2010 πŸ› Springer-Verlag 🌐 English βš– 450 KB

## Purpose In malignant tumors, predictive markers have been developed with respect to targeted therapies. One of the first targeted therapies was the hormone-blocking treatment of tumors of the male and female reproductive system. A typical therapy in breast cancer is the use of the selective estr

Cytosine deaminase gene as a potential t
Cytosine deaminase gene as a potential tool for the genetic therapy of colorectal cancer
✍ Rowley, Simon; Lindauer, Marcus; Gebert, Johannes F.; Haberkorn, Uwe; Oberdorfer πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 632 KB

The bacterial enzyme cytosine deaminase (CD) catalyzes the conversion of 5-fluorocytosine (5-FC) to the lethal 5-fluorouracil (5-Fu) and so provides a useful system for selective killing of gene-modified mammalian tumor cells. Cloning of the CD gene from Escherichiu coli and expression in human tumo